ARVO Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chavis, P.S.
Right arrow Articles by Allen, R.C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chavis, P.S.
Right arrow Articles by Allen, R.C.
Invest Ophthalmol Vis Sci 2003;44: E-Abstract 5038.
© 2003 ARVO


5038—B697

Risk Factors for Age-Related Macular Degeneration

P.S. Chavis1, I.G. Castillo1, S.G. Schwartz1, C.T. Leffler1, K.S. Kishor1 and R.C. Allen1

1 Ophthalmology, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, VA, United States

Commercial Relationships: P.S. Chavis, None; I.G. Castillo, None; S.G. Schwartz, Novartis R; C.T. Leffler, None; K.S. Kishor, None; R.C. Allen, Merck Sharp & Dome C, R; Pharmacia C, R.

Abstract

Purpose: To evaluate the association between age-related macular degeneration (AMD) and diet, alcohol intake, medications, and smoking.
Methods: One hundred one AMD patients and 102 controls with other eye conditions were identified from the clinical database of the Hunter Holmes McGuire Veterans Administration Medical Center, Richmond, VA. A detailed questionnaire including diet, alcohol intake, smoking, and medication history was completed for each participant. A medical record review was conducted to identify body mass index, major medical conditions, and use of systemic medications. The ocular examination was recorded, and AMD was graded according to the Age-Related Eye Disease Study (AREDS) classification. Univariate and multivariable analyses were performed.
Results: The mean age was 77 years for cases and 74 for controls. The mean AREDS stage in the worse eye was 2.7 for cases. Diabetes and glaucoma were more common in the control subjects. Blue irides were associated with macular degeneration in a univariate analysis (p < 0.001). Use of Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) for greater than 1 year was less common in cases (39%) compared with controls (56%, p = 0.01). The independent predictors of the severity of macular degeneration by multivariable linear regression were age (p = 0.001), family history (p < 0.001), white race (p < 0.001), pack-years of cigarette smoking (p = 0.04), and years of statin treatment (p = 0.002). Statin treatment was negatively associated. Alcohol use and fruit and vegetable intake were not associated with macular degeneration
Conclusions: In our series, the following risk factors were associated with AMD: age, race, family history, cigarette smoking, and absence of statin treatment. Smoking is an avoidable risk factor for AMD and patients should be counseled about the ocular risks of cigarette smoking. Statins may be protective against severe AMD, and a prospective trial may be indicated.

Keywords: retina • age-related macular degeneration • clinical (human) or epidemiologic studies: ris

 © 2003, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. For permission to reproduce any part of this abstract, contact the ARVO Office at arvo{at}arvo.org.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH